Would it be flip of me to say, “A whole bunch of stuff?” It’s one of the main reasons I was attracted to the practice in the ...

Ionis Pharmaceuticals, Inc. shows promise with new drug launches and a robust pipeline. Click here to read IONS stock ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...

Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Researchers found that COVID-19 mRNA vaccines, when given within 100 days of starting immune checkpoint inhibitors, were ...

Background: System vaccinology identified an early innate signature associated with vaccine-mediated protection whose induction is likely to involve both immune and non-immune cells. Methods: To ...

The abrupt termination last month of nearly half a billion dollars in US government contracts for mRNA vaccine research rattled scientists working inside and outside industry. The cuts raised alarm ...